Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Tyrphostin 23

🥰Excellent
Catalog No. T2063Cas No. 118409-57-7
Alias Tyrphostin A23, TX 825, RG-50810, AG18

Tyrphostin 23 (AG18) inhibits EGFR with IC50 of 35 μM.

Tyrphostin 23

Tyrphostin 23

🥰Excellent
Purity: 99.7%
Catalog No. T2063Alias Tyrphostin A23, TX 825, RG-50810, AG18Cas No. 118409-57-7
Tyrphostin 23 (AG18) inhibits EGFR with IC50 of 35 μM.
Pack SizePriceAvailabilityQuantity
10 mg$54In Stock
25 mg$124In Stock
50 mg$236In Stock
100 mg$355In Stock
1 mL x 10 mM (in DMSO)$36In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Tyrphostin 23"

Select Batch
Purity:99.7%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Tyrphostin 23 (AG18) inhibits EGFR with IC50 of 35 μM.
Targets&IC50
EGFR:35 μM
In vivo
AG18 inhibits the volume-sensitive release of [3H] taurine in primary astrocyte cultures in a dose-dependent manner. Additionally, AG18 suppresses EGF-induced autophosphorylation of EGFR in A431 cells with an IC50 value of 15 μM and inhibits the proliferation of GH3 cells induced by EGF at a concentration of 10 μM. At the same concentration, AG18 also prevents the increase in ERK1/2 phosphorylation stimulated by Ghrelin in GH3 cells and counteracts 2xKCl-induced contractions, exerting maximal inhibitory effects. At 100 μM, AG18 blocks the activity of IKK stimulated by TNF-alpha and TPA in A549 epithelial cells. Furthermore, at a concentration of 300 μM, it dose-dependently inhibits the stimulation of ICAM-1 expression induced by TPA in A549 epithelial cells. Additionally, at this concentration, AG18 also hampers the TPA-stimulated NF-kappaB DNA-binding and ICAM-1 promoter activity in A549 epithelial cells.
Kinase Assay
EGF-Receptor Autophosphorylation: WGA-purified EGF receptor from A431 cells (0.5 μg/assay) is activated with EGF (800 nM) for 20 min at 4 ℃. The reaction is initiated by the addition of Mg(Ac)2 (60 mM), Tris-Mes buffer, pH 7.6 (50 mM), and [32P]ATP (20 pM, 5 μCi/assay). The reaction is conducted at either 4 ℃ or 15 ℃ and terminated by addition of sodium dodecyl sulfate (SDS) sample buffer (10% glycerol, 50 mM Tris, pH 6.8, 5% β-mercaptoethanol, and 3% SDS). The samples are run on a 8% SDS polyacrylamide gel (SDS-PAGE) (prepared from 30% acrylamide and 0.8% bis-(acrylamide) and contained 0.375 M Tris, pH 8.8, 0.1% SDS, 0.05% TEMED, and 0.46% ammonium persulfate). The gel is dried and autoradiography is perfromed with Agfa Curix RP2 X-ray film. The relevant radioactive bands are cut and counted in the Cerenkov mode. The fast phase of autophosphorylation continued for another 10 min. The extent of phosphorylation completed in the first 10 s at 15 ℃ comprises 1/3 of the total autophosphorylation signal and probably reflects the phosphorylation of the first site on the receptor. The 10-s interval is therefore chosen for use in subsequent autophosphorylation experiments.
Cell Research
GH3 cells are plated at 5 × 104 cells/well in media containing 2% charcoal-stripped FCS and various concentrations of ghrelin, desoctanoylated ghrelin and PMA or EGF for 72 hours with the addition of 2 μCi/well [3H]thymidine for a further 6 hours. A time-course of 24 hours, 48 hours and 72 hours is performed for ghrelin stimulation and 72 hours is selected for further experiments. Studies are also performed to investigate the effect of rat ghrelin or desoctanoyl ghrelin-induced proliferation and the effect of U0126, GF109203X, AG 18, wortmannin and H-89 upon ghrelin-induced MAPK stimulation. AG 18 at 10 μM is added 30 min before each treatment. Cells are harvested before counting in the presence of scintillation fluid using a Microbeta 1450 bcounter. Experiments are repeated at least three times.(Only for Reference)
AliasTyrphostin A23, TX 825, RG-50810, AG18
Chemical Properties
Molecular Weight186.17
FormulaC10H6N2O2
Cas No.118409-57-7
SmilesOc1ccc(C=C(C#N)C#N)cc1O
Relative Density.1.428 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
Ethanol: 35 mg/mL (188 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 35 mg/mL (188 mM)
Solution Preparation Table
Ethanol/DMSO
1mg5mg10mg50mg
1 mM5.3714 mL26.8572 mL53.7143 mL268.5717 mL
5 mM1.0743 mL5.3714 mL10.7429 mL53.7143 mL
10 mM0.5371 mL2.6857 mL5.3714 mL26.8572 mL
20 mM0.2686 mL1.3429 mL2.6857 mL13.4286 mL
50 mM0.1074 mL0.5371 mL1.0743 mL5.3714 mL
100 mM0.0537 mL0.2686 mL0.5371 mL2.6857 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Tyrphostin 23 | purchase Tyrphostin 23 | Tyrphostin 23 cost | order Tyrphostin 23 | Tyrphostin 23 chemical structure | Tyrphostin 23 in vivo | Tyrphostin 23 formula | Tyrphostin 23 molecular weight